<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36536341</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1423-0127</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of biomedical science</Title><ISOAbbreviation>J Biomed Sci</ISOAbbreviation></Journal><ArticleTitle>Modulation of histone H3K4 dimethylation by spermidine ameliorates motor neuron survival and neuropathology in a mouse model of ALS.</ArticleTitle><Pagination><StartPage>106</StartPage><MedlinePgn>106</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">106</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12929-022-00890-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive paralysis due to motor neuron degeneration. It has been proposed that epigenetic modification and transcriptional dysregulation may contribute to motor neuron death. In this study, we investigate the basis for therapeutic approaches to target lysine-specific histone demethylase 1 (LSD1) and elucidate the mechanistic role of LSD1-histone H3K4 signaling pathway in ALS pathogenesis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In order to examine the role of spermidine (SD), we administered SD to an animal model of ALS (G93A) and performed neuropathological analysis, body weight, and survival evaluation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Herein, we found that LSD1 activity is increased while levels of H3K4me2, a substrate of LSD1, is decreased in cellular and animal models of ALS. SD administration modulated the LSD1 activity and restored H3K4me2 levels in ChAT-positive motor neurons in the lumbar spinal cord of ALS mice. SD prevented cellular damage by improving the number and size of motor neurons in ALS mice. SD administration also reduced GFAP-positive astrogliogenesis in the white and gray matter of the lumbar spinal cord, improving the neuropathology of ALS mice. Moreover, SD administration improved the rotarod performance and gait analysis of ALS mice. Finally, SD administration delayed disease onset and prolonged the lifespan of ALS (G93A) transgenic mice.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Together, modulating epigenetic targets such as LSD1 by small compounds may be a useful therapeutic strategy for treating ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Choi</LastName><ForeName>Seung-Hye</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>K-Laboratory, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yousefian-Jazi</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>K-Laboratory, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyeon</LastName><ForeName>Seung Jae</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>K-Laboratory, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Phuong Thi Thanh</ForeName><Initials>PTT</Initials><AffiliationInfo><Affiliation>K-Laboratory, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KIST School, Division of Bio-Medical Science &amp; Technology, University of Science and Technology (UST), Seoul, 02792, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Jiyeon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>K-Laboratory, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Integrated Biomedical and Life Science Department, Graduate School, Korea University, Seoul, 02841, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sojung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>K-Laboratory, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Suhyun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>K-Laboratory, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Hannah L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Boston University Alzheimer's Disease Research Center, Boston University School of Medicine, Boston, MA, 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowall</LastName><ForeName>Neil W</ForeName><Initials>NW</Initials><AffiliationInfo><Affiliation>Department of Neurology, Boston University Alzheimer's Disease Research Center, Boston University School of Medicine, Boston, MA, 02118, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Boston Healthcare System, 150 S. Huntington Avenue, Boston, MA, 02130, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Hoon</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6544-3732</Identifier><AffiliationInfo><Affiliation>K-Laboratory, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, South Korea. hoonryu@kist.re.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KIST School, Division of Bio-Medical Science &amp; Technology, University of Science and Technology (UST), Seoul, 02792, South Korea. hoonryu@kist.re.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Junghee</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Boston University Alzheimer's Disease Research Center, Boston University School of Medicine, Boston, MA, 02118, USA. junghee@bu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Boston Healthcare System, 150 S. Huntington Avenue, Boston, MA, 02130, USA. junghee@bu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS109537</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01NS109537</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Biomed Sci</MedlineTA><NlmUniqueID>9421567</NlmUniqueID><ISSNLinking>1021-7770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>U87FK77H25</RegistryNumber><NameOfSubstance UI="D013095">Spermidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006657">Histones</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013095" MajorTopicYN="N">Spermidine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006657" MajorTopicYN="N">Histones</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Histone H3K4 dimethylation</Keyword><Keyword MajorTopicYN="N">LSD1</Keyword><Keyword MajorTopicYN="N">Motor neuron</Keyword><Keyword MajorTopicYN="N">Spermidine</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>19</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36536341</ArticleId><ArticleId IdType="pmc">PMC9764677</ArticleId><ArticleId IdType="doi">10.1186/s12929-022-00890-3</ArticleId><ArticleId IdType="pii">10.1186/s12929-022-00890-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32(5):771&#x2013;6. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415):59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, et al. ALS-Linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18(2):327&#x2013;38. doi: 10.1016/S0896-6273(00)80272-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80272-X</ArticleId><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu H, Smith K, Camelo SI, Carreras I, Lee J, Iglesias AH, et al. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J Neurochem. 2005;93(5):1087&#x2013;98. doi: 10.1111/j.1471-4159.2005.03077.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03077.x</ArticleId><ArticleId IdType="pubmed">15934930</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros T, Kidd JD, Moreno AJ, Thompson K, Gill A, Vieira FG. A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS. J Vis Exp. 2015;104:53257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4692639</ArticleId><ArticleId IdType="pubmed">26485052</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin LJ, Wong M. Skeletal muscle-restricted expression of human SOD1 in transgenic mice causes a fatal ALS-Like Syndrome. Front Neurol. 2020;11:592851. doi: 10.3389/fneur.2020.592851.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.592851</ArticleId><ArticleId IdType="pmc">PMC7767933</ArticleId><ArticleId IdType="pubmed">33381076</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz J. Disease-modifying treatment of amyotrophic lateral sclerosis. Am J Manag Care. 2018;24(15 Suppl):327-s35.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207671</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu H, Ferrante RJ. Translational therapeutic strategies in amyotrophic lateral sclerosis. Mini Rev Med Chem. 2007;7(2):141&#x2013;50. doi: 10.2174/138955707779802570.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138955707779802570</ArticleId><ArticleId IdType="pubmed">17305588</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T, Kushida Y, Wakao S, Tadokoro K, Nomura E, Omote Y, et al. Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis. Sci Rep. 2020;10(1):17102. doi: 10.1038/s41598-020-74216-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74216-4</ArticleId><ArticleId IdType="pmc">PMC7554047</ArticleId><ArticleId IdType="pubmed">33051552</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Shen D, Gao Y, Zhou Q, Ni Y, Meng H, et al. A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed? Transl Neurodegener. 2021;10(1):29. doi: 10.1186/s40035-021-00250-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00250-5</ArticleId><ArticleId IdType="pmc">PMC8353789</ArticleId><ArticleId IdType="pubmed">34372914</ArticleId></ArticleIdList></Reference><Reference><Citation>Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7(1):65&#x2013;74. doi: 10.2174/157015909787602823.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157015909787602823</ArticleId><ArticleId IdType="pmc">PMC2724665</ArticleId><ArticleId IdType="pubmed">19721819</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Sawalha AH. The role of oxidative stress in epigenetic changes underlying autoimmunity. Antioxid Redox Signal. 2022;36(7&#x2013;9):423&#x2013;40. doi: 10.1089/ars.2021.0066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2021.0066</ArticleId><ArticleId IdType="pmc">PMC8982122</ArticleId><ArticleId IdType="pubmed">34544258</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivas S, Baghel MS, Singh P, Thakur MK. Neurodegeneration during aging: the role of oxidative stress through epigenetic modifications. In: Rath PC, editor. Models, molecules and mechanisms in biogerontology: physiological abnormalities, diseases and interventions. Singapore: Springer; 2019. pp. 43&#x2013;55.</Citation></Reference><Reference><Citation>Carr&#xec; MT, Valle C, Bozzo F, Cozzolino M. Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS. Front Cell Neurosci. 2015;9:41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4330888</ArticleId><ArticleId IdType="pubmed">25741238</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Rozhkov NV, Shaw R, Kim D, Hubbard I, Fennessey S, et al. Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia. Cell Rep. 2019;29(5):1164&#x2013;77.e5. doi: 10.1016/j.celrep.2019.09.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha-Oliveira T, Montezinho L, Mendes C, Firuzi O, Saso L, Oliveira PJ, et al. Oxidative stress in amyotrophic lateral sclerosis: pathophysiology and opportunities for pharmacological intervention. Oxid Med Cell Longev. 2020;2020:5021694. doi: 10.1155/2020/5021694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5021694</ArticleId><ArticleId IdType="pmc">PMC7683149</ArticleId><ArticleId IdType="pubmed">33274002</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D, Daura X, Zagrovic B. Effect of oxidative damage on the stability and dimerization of superoxide dismutase 1. Biophys J. 2016;110(7):1499&#x2013;509. doi: 10.1016/j.bpj.2016.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2016.02.037</ArticleId><ArticleId IdType="pmc">PMC4833831</ArticleId><ArticleId IdType="pubmed">27074676</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemerkov&#xe1; P, Vali&#x161; M. Role of oxidative stress in the pathogenesis of amyotrophic lateral sclerosis: antioxidant metalloenzymes and therapeutic strategies. Biomolecules. 2021;11(3):437. doi: 10.3390/biom11030437.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11030437</ArticleId><ArticleId IdType="pmc">PMC8002298</ArticleId><ArticleId IdType="pubmed">33809730</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Mavel S, Corcia P, Gordon PH. The glutamate hypothesis in ALS: pathophysiology and drug development. Curr Med Chem. 2014;21(31):3551&#x2013;75. doi: 10.2174/0929867321666140916120118.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867321666140916120118</ArticleId><ArticleId IdType="pubmed">25245510</ArticleId></ArticleIdList></Reference><Reference><Citation>Foran E, Trotti D. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid Redox Signal. 2009;11(7):1587&#x2013;602. doi: 10.1089/ars.2009.2444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2444</ArticleId><ArticleId IdType="pmc">PMC2842587</ArticleId><ArticleId IdType="pubmed">19413484</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazama M, Kato Y, Kakita A, Noguchi N, Urano Y, Masui K, et al. Astrocytes release glutamate via cystine/glutamate antiporter upregulated in response to increased oxidative stress related to sporadic amyotrophic lateral sclerosis. Neuropathology. 2020;40(6):587&#x2013;98. doi: 10.1111/neup.12716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12716</ArticleId><ArticleId IdType="pubmed">33305472</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Ryu H, Kowall NW. Motor neuronal protection by L-arginine prolongs survival of mutant SOD1 (G93A) ALS mice. Biochem Biophys Res Commun. 2009;384(4):524&#x2013;9. doi: 10.1016/j.bbrc.2009.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.05.015</ArticleId><ArticleId IdType="pmc">PMC2744197</ArticleId><ArticleId IdType="pubmed">19427829</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Ryu H, Ferrante RJ, Morris SM, Ratan RR. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci. 2003;100(8):4843. doi: 10.1073/pnas.0735876100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0735876100</ArticleId><ArticleId IdType="pmc">PMC153643</ArticleId><ArticleId IdType="pubmed">12655043</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Huang Y, Marton LJ, Woster PM, Davidson NE, Casero RA. Jr. Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells. Amino Acids. 2012;42(2&#x2013;3):887&#x2013;98. doi: 10.1007/s00726-011-1004-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-011-1004-1</ArticleId><ArticleId IdType="pmc">PMC3240695</ArticleId><ArticleId IdType="pubmed">21805138</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Hevi S, Kurash JK, Lei H, Gay F, Bajko J, et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet. 2009;41(1):125&#x2013;9. doi: 10.1038/ng.268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.268</ArticleId><ArticleId IdType="pubmed">19098913</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G-J, Lei P-M, Wong S-Y, Ma D-L, Leung C-H. Pharmacological inhibition of LSD1 for cancer treatment. Molecules. 2018;23(12):3194. doi: 10.3390/molecules23123194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23123194</ArticleId><ArticleId IdType="pmc">PMC6320820</ArticleId><ArticleId IdType="pubmed">30518104</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand R, Marmorstein R. Structure and mechanism of lysine-specific demethylase enzymes. J Biol Chem. 2007;282(49):35425&#x2013;9. doi: 10.1074/jbc.R700027200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R700027200</ArticleId><ArticleId IdType="pubmed">17897944</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, Richter M, et al. p53 is regulated by the lysine demethylase LSD1. Nature. 2007;449(7158):105&#x2013;8. doi: 10.1038/nature06092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06092</ArticleId><ArticleId IdType="pubmed">17805299</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y, Liao G, Yu B. LSD1/KDM1A inhibitors in clinical trials: advances and prospects. J Hematol Oncol. 2019;12(1):129. doi: 10.1186/s13045-019-0811-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-019-0811-9</ArticleId><ArticleId IdType="pmc">PMC6894138</ArticleId><ArticleId IdType="pubmed">31801559</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y, Yang C, Yu Z, Li X, Mu Q, Liao G, et al. Natural products as LSD1 inhibitors for cancer therapy. Acta Pharm Sin B. 2020;11:621&#x2013;631. doi: 10.1016/j.apsb.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7305746</ArticleId><ArticleId IdType="pubmed">32837872</ArticleId></ArticleIdList></Reference><Reference><Citation>Mould DP, McGonagle AE, Wiseman DH, Williams EL, Jordan AM. Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to date. Med Res Rev. 2015;35(3):586&#x2013;618. doi: 10.1002/med.21334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21334</ArticleId><ArticleId IdType="pubmed">25418875</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulding T, McCuaig RD, Tan A, Hardy K, Wu F, Dunn J, et al. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer. Sci Rep. 2018;8(1):73. doi: 10.1038/s41598-017-17913-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17913-x</ArticleId><ArticleId IdType="pmc">PMC5758711</ArticleId><ArticleId IdType="pubmed">29311580</ArticleId></ArticleIdList></Reference><Reference><Citation>Binda C, Newton-Vinson P, Hub&#xe1;lek F, Edmondson DE, Mattevi A. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat Struct Biol. 2002;9(1):22&#x2013;6. doi: 10.1038/nsb732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsb732</ArticleId><ArticleId IdType="pubmed">11753429</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Culhane JC, Szewczuk LM, Jalili P, Ball HL, Machius M, et al. Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. Biochemistry. 2007;46(27):8058&#x2013;65. doi: 10.1021/bi700664y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi700664y</ArticleId><ArticleId IdType="pubmed">17569509</ArticleId></ArticleIdList></Reference><Reference><Citation>Finberg JPM, Rabey JM. Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Front Pharmacol. 2016;7:340. doi: 10.3389/fphar.2016.00340.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2016.00340</ArticleId><ArticleId IdType="pmc">PMC5067815</ArticleId><ArticleId IdType="pubmed">27803666</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick PF. Oxidation of amines by flavoproteins. Arch Biochem Biophys. 2010;493(1):13&#x2013;25. doi: 10.1016/j.abb.2009.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2009.07.019</ArticleId><ArticleId IdType="pmc">PMC2812625</ArticleId><ArticleId IdType="pubmed">19651103</ArticleId></ArticleIdList></Reference><Reference><Citation>Forneris F, Binda C, Battaglioli E, Mattevi A. LSD1: oxidative chemistry for multifaceted functions in chromatin regulation. Trends Biochem Sci. 2008;33(4):181&#x2013;9. doi: 10.1016/j.tibs.2008.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2008.01.003</ArticleId><ArticleId IdType="pubmed">18343668</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumenko N, Pollari E, Kurronen A, Giniatullina R, Shakirzyanova A, Magga J, et al. Gender-specific mechanism of synaptic impairment and its prevention by GCSF in a mouse model of ALS. Front Cell Neurosci. 2011;5:26. doi: 10.3389/fncel.2011.00026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2011.00026</ArticleId><ArticleId IdType="pmc">PMC3238042</ArticleId><ArticleId IdType="pubmed">22180738</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Ryu H, Kowall NW. Differential regulation of neuronal and inducible nitric oxide synthase (NOS) in the spinal cord of mutant SOD1 (G93A) ALS mice. Biochem Biophys Res Commun. 2009;387(1):202&#x2013;6. doi: 10.1016/j.bbrc.2009.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.07.007</ArticleId><ArticleId IdType="pmc">PMC2742676</ArticleId><ArticleId IdType="pubmed">19580782</ArticleId></ArticleIdList></Reference><Reference><Citation>Luh LM, Das I, Bertolotti A. qMotor, a set of rules for sensitive, robust and quantitative measurement of motor performance in mice. Nat Protoc. 2017;12(7):1451&#x2013;7. doi: 10.1038/nprot.2017.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2017.062</ArticleId><ArticleId IdType="pmc">PMC5568708</ArticleId><ArticleId IdType="pubmed">28686587</ArticleId></ArticleIdList></Reference><Reference><Citation>Heikkinen T, Bragge T, Bhattarai N, Parkkari T, Puoliv&#xe4;li J, Kontkanen O, et al. Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington&#x2019;s disease. PLoS ONE. 2020;15(12):e0243052. doi: 10.1371/journal.pone.0243052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243052</ArticleId><ArticleId IdType="pmc">PMC7769440</ArticleId><ArticleId IdType="pubmed">33370315</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012;29(1):15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Pyl PT, Huber W. HTSeq&#x2013;a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166&#x2013;9. doi: 10.1093/bioinformatics/btu638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu638</ArticleId><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357&#x2013;9. doi: 10.1038/nmeth.1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1923</ArticleId><ArticleId IdType="pmc">PMC3322381</ArticleId><ArticleId IdType="pubmed">22388286</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38(4):576&#x2013;89. doi: 10.1016/j.molcel.2010.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.05.004</ArticleId><ArticleId IdType="pmc">PMC2898526</ArticleId><ArticleId IdType="pubmed">20513432</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiques-Diaz A, Lynch JT, Spencer GJ, Somervaille TCP. LSD1 inhibitors disrupt the GFI1 transcription repressor complex. Mol Cell Oncol. 2018;5(4):e1481813-e. doi: 10.1080/23723556.2018.1481813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23723556.2018.1481813</ArticleId><ArticleId IdType="pmc">PMC6150006</ArticleId><ArticleId IdType="pubmed">30250927</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrafiah AR. Evaluation of the role of an antioxidant gene in NSC-34 motor neuron-like cells as a model of a motor neuron disease. Folia Morphol (Warsz) 2019;78(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30106460</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Chen S, Zhang Y, Lin X, Song Y, Xue Z, et al. Induction of autophagy by spermidine is neuroprotective via inhibition of caspase 3-mediated beclin 1 cleavage. Cell Death Dis. 2017;8(4):e2738-e. doi: 10.1038/cddis.2017.161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2017.161</ArticleId><ArticleId IdType="pmc">PMC5477584</ArticleId><ArticleId IdType="pubmed">28383560</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I-F, Guo B-S, Liu Y-C, Wu C-C, Yang C-H, Tsai K-J, et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci. 2012;109(37):15024&#x2013;9. doi: 10.1073/pnas.1206362109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206362109</ArticleId><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Diler AS, Ziylan YZ, Uzum G, Lefauconnier JM, Seylaz J, Pinard E. Passage of spermidine across the blood&#x2013;brain barrier in short recirculation periods following global cerebral ischemia: effects of mild hyperthermia. Neurosci Res. 2002;43(4):335&#x2013;42. doi: 10.1016/S0168-0102(02)00059-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-0102(02)00059-7</ArticleId><ArticleId IdType="pubmed">12135777</ArticleId></ArticleIdList></Reference><Reference><Citation>Glantz L, Nates JL, Trembovler V, Bass R, Shohami E. Polyamines induce blood-brain barrier disruption and edema formation in the rat. J Basic Clin Physiol Pharmacol. 1996;7(1):1&#x2013;10. doi: 10.1515/JBCPP.1996.7.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/JBCPP.1996.7.1.1</ArticleId><ArticleId IdType="pubmed">8983332</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, et al. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Rev. 2004;47(1):263&#x2013;74. doi: 10.1016/j.brainresrev.2004.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2004.05.003</ArticleId><ArticleId IdType="pubmed">15572176</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008;11(3):251&#x2013;3. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai J, Cannav&#xf2; E, Crabtree GW, Sun Z, Diamantopoulou A, Thakur P, et al. Recapitulation and reversal of schizophrenia-related phenotypes in Setd1a-deficient mice. Neuron. 2019;104(3):471&#x2013;87.e12. doi: 10.1016/j.neuron.2019.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.09.014</ArticleId><ArticleId IdType="pmc">PMC7010348</ArticleId><ArticleId IdType="pubmed">31606247</ArticleId></ArticleIdList></Reference><Reference><Citation>Hezroni H, Ben-Tov Perry R, Gil N, Degani N, Ulitsky I. Regulation of neuronal commitment in mouse embryonic stem cells by the Reno1/Bahcc1 locus. EMBO Rep. 2020;21(11):e51264. doi: 10.15252/embr.202051264.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202051264</ArticleId><ArticleId IdType="pmc">PMC7645239</ArticleId><ArticleId IdType="pubmed">32969152</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawardana CG, Mehrabian M, Wang X, Mueller I, Lubambo IB, Jonkman JE, et al. The human tau interactome: binding to the Ribonucleoproteome, and impaired binding of the proline-to-leucine mutant at position 301 (P301L) to chaperones and the Proteasome. Mol Cell Proteomics. 2015;14(11):3000&#x2013;14. doi: 10.1074/mcp.M115.050724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M115.050724</ArticleId><ArticleId IdType="pmc">PMC4638042</ArticleId><ArticleId IdType="pubmed">26269332</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrozziello T, Amaral AC, Dujardin S, Farhan SMK, Chan J, Trombetta BA, et al. Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid. Brain Pathol. 2022;32:e13035. doi: 10.1111/bpa.13035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.13035</ArticleId><ArticleId IdType="pmc">PMC8877756</ArticleId><ArticleId IdType="pubmed">34779076</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381&#x2013;95. doi: 10.1038/cr.2011.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2011.22</ArticleId><ArticleId IdType="pmc">PMC3193420</ArticleId><ArticleId IdType="pubmed">21321607</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett SA, Tanaz R, Cobos SN, Torrente MP. Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease. Translational Res. 2019;204:19&#x2013;30. doi: 10.1016/j.trsl.2018.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2018.10.002</ArticleId><ArticleId IdType="pmc">PMC6331271</ArticleId><ArticleId IdType="pubmed">30391475</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence M, Daujat S, Schneider R. Lateral thinking: how histone modifications regulate Gene expression. Trends Genet. 2016;32(1):42&#x2013;56. doi: 10.1016/j.tig.2015.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2015.10.007</ArticleId><ArticleId IdType="pubmed">26704082</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, et al. Histone demethylation mediated by the Nuclear Amine Oxidase Homolog LSD1. Cell. 2004;119(7):941&#x2013;53. doi: 10.1016/j.cell.2004.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.12.012</ArticleId><ArticleId IdType="pubmed">15620353</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark EA, Wu F, Chen Y, Kang P, Kaiser UB, Fang R, et al. GR and LSD1/KDM1A-Targeted gene activation requires selective H3K4me2 demethylation at Enhancers. Cell Rep. 2019;27(12):3522&#x2013;2.e3. doi: 10.1016/j.celrep.2019.05.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.05.062</ArticleId><ArticleId IdType="pmc">PMC7433711</ArticleId><ArticleId IdType="pubmed">31216473</ArticleId></ArticleIdList></Reference><Reference><Citation>Perillo B, Tramontano A, Pezone A, Migliaccio A. LSD1: more than demethylation of histone lysine residues. Exp Mol Med. 2020;52(12):1936&#x2013;47. doi: 10.1038/s12276-020-00542-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-020-00542-2</ArticleId><ArticleId IdType="pmc">PMC8080763</ArticleId><ArticleId IdType="pubmed">33318631</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi YJ, Matson C, Lan F, Iwase S, Baba T, Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell. 2005;19(6):857&#x2013;64. doi: 10.1016/j.molcel.2005.08.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2005.08.027</ArticleId><ArticleId IdType="pubmed">16140033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S-A, Zhu J, Yennawar N, Eek P, Tan S. Crystal structure of the LSD1/CoREST histone demethylase bound to its nucleosome substrate. Mol Cell. 2020;78(5):903&#x2013;14.e4. doi: 10.1016/j.molcel.2020.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.04.019</ArticleId><ArticleId IdType="pmc">PMC7275924</ArticleId><ArticleId IdType="pubmed">32396821</ArticleId></ArticleIdList></Reference><Reference><Citation>Javed S, Selliah T, Lee Y-J, Huang W-H. Dosage-sensitive genes in autism spectrum disorders: from neurobiology to therapy. Neurosci Biobehav Rev. 2020;118:538&#x2013;67. doi: 10.1016/j.neubiorev.2020.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2020.08.009</ArticleId><ArticleId IdType="pubmed">32858083</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopher MA, Myrick DA, Barwick BG, Engstrom AK, Porter-Stransky KA, Boss JM, et al. LSD1 protects against hippocampal and cortical neurodegeneration. Nat Commun. 2017;8(1):805. doi: 10.1038/s41467-017-00922-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00922-9</ArticleId><ArticleId IdType="pmc">PMC5634471</ArticleId><ArticleId IdType="pubmed">28993646</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang B, Chen Y, Zhao Y, Bruick RK. JMJD6 is a histone arginine demethylase. Science. 2007;318(5849):444&#x2013;7. doi: 10.1126/science.1145801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1145801</ArticleId><ArticleId IdType="pubmed">17947579</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Greene E, Murray Stewart T, Goodwin AC, Baylin SB, Woster PM, et al. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc Natl Acad Sci. 2007;104(19):8023. doi: 10.1073/pnas.0700720104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0700720104</ArticleId><ArticleId IdType="pmc">PMC1857229</ArticleId><ArticleId IdType="pubmed">17463086</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinckier NK, Patel NA, Geusz RJ, Wang A, Wang J, Matta I, et al. LSD1-mediated enhancer silencing attenuates retinoic acid signalling during pancreatic endocrine cell development. Nat Commun. 2020;11(1):2082. doi: 10.1038/s41467-020-16017-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16017-x</ArticleId><ArticleId IdType="pmc">PMC7190832</ArticleId><ArticleId IdType="pubmed">32350257</ArticleId></ArticleIdList></Reference><Reference><Citation>Holshouser S, Dunworth M, Murray-Stewart T, Peterson YK, Burger P, Kirkpatrick J, et al. Dual inhibitors of LSD1 and spermine oxidase. Medchemcomm. 2019;10(5):778&#x2013;90. doi: 10.1039/C8MD00610E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8MD00610E</ArticleId><ArticleId IdType="pmc">PMC6533887</ArticleId><ArticleId IdType="pubmed">31191868</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegg AE. The function of spermine. IUBMB Life. 2014;66(1):8&#x2013;18. doi: 10.1002/iub.1237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1237</ArticleId><ArticleId IdType="pubmed">24395705</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>